FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers

NCT02359357 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: FDL169
DRUG: Placebo

Sponsor

Flatley Discovery Lab LLC